HIV :: FDA approves Merck’s Isentress, raltegravir tablets for HIV AIDS

Merck & Co., Inc., announced that the U.S. Food and Drug Administration (FDA) granted ISENTRESS TM (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

HIV :: Enhanced support to AIDS prevention and care programme in north eastern states, India

The Indian Minister of State for Health & Family Welfare, Smt. Panabaka Lakshmi launched the Joint UN Programme on HIV and AIDS Prevention and Care in the North-Eastern States. This is a unique endeavour, which demonstrates a strong partnership between the Government of India, the UN system and the donors, the Governments of Australia and Sweden to improve the quality of and augment response to the HIV epidemic in North-East India.

HIV :: Global HIV Vaccine Enterprise names Alan Bernstein as Inaugural Executive Director

At the Keystone Symposium in Cape Town, the Global HIV Vaccine Enterprise announced the appointment of its first executive director and the opening of a new secretariat in New York City. Dr. Alan Bernstein, founding president of the Canadian Institutes of Health Research, will lead the international alliance of researchers, funders and advocates dedicated to speeding the search for an HIV vaccine.